Table 3.
Variables | Recurrence | Overall survival | ||
---|---|---|---|---|
HR (95% CI) | P | HR (95% CI) | P | |
Microvascular invasion (yes versus no) | 1.571 (1.008–2.449) | 0.046 | 1.808 (1.262–2.590) | 0.001 |
LN metastasis (yes versus no) | N.A. | N.A. | 2.964 (0.909–9.664) | 0.072 |
No. of tumors (multi versus single) | 0.926 (0.594–1.444) | 0.735 | 0.990 (0.661–1.482) | 0.960 |
Tumor size (>5 cm versus ≤5cm) | 1.719 (1.132–2.611) | 0.011 | 1.116 (0.768–1.622) | 0.564 |
CA199 (>37 U/ml versus ≤37 U/ml) | 1.271 (0.868–1.861) | 0.217 | 1.474 (1.046–2.077) | 0.027 |
CEA (>5 ng/ml versus ≤5 ng/ml) | 1.132 (0.734–1.745) | 0.574 | 1.909 (1.346–2.709) | <0.001 |
GGT (>60 U/l versus ≤60 U/l) | 1.454 (1.000–2.115) | 0.050 | 1.675 (1.174–2.389) | 0.004 |
AJCC 8th (IIIa–IIIb versus I–II) | N.A. | N.A. | 0.814 (0.253–2.620) | 0.730 |
SPP1+ TAMs (high versus low) | 2.613 (1.805–3.783) | <0.001 | 1.701 (1.225–2.361) | 0.002 |
HR, hazard ratio; CI, confidence interval; NA, not available.
Bold indicated statistical significance.